| First Author | Aldeiri B | Year | 2017 |
| Journal | Development | Volume | 144 |
| Issue | 18 | Pages | 3336-3348 |
| PubMed ID | 28807903 | Mgi Jnum | J:245883 |
| Mgi Id | MGI:5919301 | Doi | 10.1242/dev.152843 |
| Citation | Aldeiri B, et al. (2017) Transgelin-expressing myofibroblasts orchestrate ventral midline closure through TGFbeta signalling. Development 144(18):3336-3348 |
| abstractText | Ventral body wall (VBW) defects are among the most common congenital malformations, yet their embryonic origin and underlying molecular mechanisms remain poorly characterised. Transforming growth factor beta (TGFbeta) signalling is essential for VBW closure, but the responding cells are not known. Here, we identify in mouse a population of migratory myofibroblasts at the leading edge of the closing VBW that express the actin-binding protein transgelin (TAGLN) and TGFbeta receptor (TGFbetaR). These cells respond to a temporally regulated TGFbeta2 gradient originating from the epithelium of the primary body wall. Targeted elimination of TGFbetaR2 in TAGLN+ cells impairs midline closure and prevents the correct subsequent patterning of the musculature and skeletal components. Remarkably, deletion of Tgfbr2 in myogenic or chondrogenic progenitor cells does not manifest in midline defects. Our results indicate a pivotal significance of VBW myofibroblasts in orchestrating ventral midline closure by mediating the response to the TGFbeta gradient. Altogether, our data enable us to distinguish highly regulated epithelial-mesenchymal signalling and successive cellular migration events in VBW closure that explain early morphological changes underlying the development of congenital VBW defects. |
